These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 39114356)

  • 1. Dynamic phenotypic shifts and M2 receptor downregulation in bladder smooth muscle cells induced by mirabegron.
    Muderrisoglu AE; Ciotkowska A; Rutz B; Hu S; Qian S; Tamalunas A; Stief CG; Hennenberg M
    Front Pharmacol; 2024; 15():1446831. PubMed ID: 39114356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Full Smooth Muscle Contraction in Isolated Human Detrusor Tissues by Mirabegron Is Limited to Off-Target Inhibition of Neurogenic Contractions.
    Huang R; Tamalunas A; Waidelich R; Strittmatter F; Stief CG; Hennenberg M
    J Pharmacol Exp Ther; 2022 May; 381(2):176-187. PubMed ID: 35153197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration-dependent alpha
    Huang R; Liu Y; Ciotkowska A; Tamalunas A; Waidelich R; Strittmatter F; Stief CG; Hennenberg M
    Front Pharmacol; 2021; 12():666047. PubMed ID: 34248624
    [No Abstract]   [Full Text] [Related]  

  • 4. Possible Involvement of Muscarinic Receptor Blockade in Mirabegron Therapy for Patients with Overactive Bladder.
    Yamada S; Chimoto J; Shiho M; Okura T; Morikawa K; Wakuda H; Shinozuka K
    J Pharmacol Exp Ther; 2021 May; 377(2):201-206. PubMed ID: 33658313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Human Prostate and Bladder Smooth Muscle Contraction, Vasoconstriction of Porcine Renal and Coronary Arteries, and Growth-Related Functions of Prostate Stromal Cells by Presumed Small Molecule Gα
    Tamalunas A; Wendt A; Springer F; Ciotkowska A; Rutz B; Wang R; Huang R; Liu Y; Schulz H; Ledderose S; Magistro G; Stief CG; Hennenberg M
    Front Physiol; 2022; 13():884057. PubMed ID: 35677088
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of Female and Male Human Detrusor Smooth Muscle Contraction by the Rac Inhibitors EHT1864 and NSC23766.
    Li B; Yu Q; Wang R; Gratzke C; Wang X; Spek A; Herlemann A; Tamalunas A; Strittmatter F; Waidelich R; Stief CG; Hennenberg M
    Front Pharmacol; 2020; 11():409. PubMed ID: 32317972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-3 Adrenoceptor Signaling Pathways in Urothelial and Smooth Muscle Cells in the Presence of Succinate.
    Mossa A; Velasquez Flores M; Nguyen H; Cammisotto PG; Campeau L
    J Pharmacol Exp Ther; 2018 Nov; 367(2):252-259. PubMed ID: 30104323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous administration of mirabegron has advantages in inhibition of central sensitization compared with short-term treatment cessation in a mouse model of overactive bladder.
    Kwon J; Lee EJ; Park HR; Cho HJ; Jang JA; Yang H; An J; Park D; Kim YJ; Hur KJ; Kim JS; Yoshimura N
    Neurourol Urodyn; 2022 Aug; 41(6):1355-1363. PubMed ID: 35556260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contribution of pharmacological research to the discovery of a first-in-class drug, mirabegron, for the treatment of overactive bladder].
    Ueshima K; Ukai M
    Nihon Yakurigaku Zasshi; 2018; 152(3):111-118. PubMed ID: 30185728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mirabegron relaxes urethral smooth muscle by a dual mechanism involving β3 -adrenoceptor activation and α1 -adrenoceptor blockade.
    Alexandre EC; Kiguti LR; Calmasini FB; Silva FH; da Silva KP; Ferreira R; Ribeiro CA; Mónica FZ; Pupo AS; Antunes E
    Br J Pharmacol; 2016 Feb; 173(3):415-28. PubMed ID: 26493129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mirabegron induces relaxant effects via cAMP signaling-dependent and -independent pathways in detrusor smooth muscle.
    Maki T; Kajioka S; Itsumi M; Kareman E; Lee K; Shiota M; Eto M
    Low Urin Tract Symptoms; 2019 Apr; 11(2):O209-O217. PubMed ID: 30632283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory imide drugs inhibit human detrusor smooth muscle contraction and growth of human detrusor smooth muscle cells, and exhibit vaso-regulatory functions.
    Tamalunas A; Wendt A; Springer F; Vigodski V; Trieb M; Eitelberger N; Poth H; Ciotkowska A; Rutz B; Hu S; Schulz H; Ledderose S; Rogenhofer N; Kolben T; Nössner E; Stief CG; Hennenberg M
    Biomed Pharmacother; 2024 Aug; 177():117066. PubMed ID: 38981242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel β3-adrenoceptor agonist mirabegron reduces carbachol-induced contractile activity in detrusor tissue from patients with bladder outflow obstruction with or without detrusor overactivity.
    Svalø J; Nordling J; Bouchelouche K; Andersson KE; Korstanje C; Bouchelouche P
    Eur J Pharmacol; 2013 Jan; 699(1-3):101-5. PubMed ID: 23246623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of LIM kinase reduces contraction and proliferation in bladder smooth muscle.
    Yu Q; Wu C; Chen Y; Li B; Wang R; Huang R; Li X; Gu D; Wang X; Duan X; Li S; Liu Y; Wu W; Hennenberg M; Zeng G
    Acta Pharm Sin B; 2021 Jul; 11(7):1914-1930. PubMed ID: 34386328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003.
    Liu Y; Wang R; Huang R; Rutz B; Ciotkowska A; Tamalunas A; Hu S; Trieb M; Waidelich R; Strittmatter F; Stief CG; Hennenberg M
    Front Pharmacol; 2023; 14():1105427. PubMed ID: 37188272
    [No Abstract]   [Full Text] [Related]  

  • 16. Rac1 silencing, NSC23766 and EHT1864 reduce growth and actin organization of bladder smooth muscle cells.
    Wang R; Yu Q; Wang X; Li B; Ciotkowska A; Rutz B; Wang Y; Stief CG; Hennenberg M
    Life Sci; 2020 Nov; 261():118468. PubMed ID: 32961232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined treatment with a β
    Imamura T; Ogawa T; Minagawa T; Nagai T; Suzuki T; Saito T; Yokoyama H; Nakazawa M; Ishizuka O
    Neurourol Urodyn; 2017 Apr; 36(4):1026-1033. PubMed ID: 27367573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of α
    Huang R; Tamalunas A; Waidelich R; Strittmatter F; Stief CG; Hennenberg M
    Biochem Pharmacol; 2022 Aug; 202():115148. PubMed ID: 35716783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mirabegron Add-on Therapy to Tamsulosin for the Treatment of Overactive Bladder in Men with Lower Urinary Tract Symptoms: A Randomized, Placebo-controlled Study (MATCH).
    Kakizaki H; Lee KS; Yamamoto O; Jong JJ; Katou D; Sumarsono B; Uno S; Yamaguchi O
    Eur Urol Focus; 2020 Jul; 6(4):729-737. PubMed ID: 31718957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta adrenergic modulation of spontaneous microcontractions and electrical field-stimulated contractions in isolated strips of rat urinary bladder from normal animals and animals with partial bladder outflow obstruction.
    Gillespie JI; Rouget C; Palea S; Granato C; Korstanje C
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Jul; 388(7):719-26. PubMed ID: 26047780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.